Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 190

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Refsum's disease: a peroxisomal disorder affecting phytanic acid α‐oxidation

Wierzbicki, Anthony S., Lloyd, Matthew D., Schofield, Christopher J., Feher, Michael D., Gibberd, F. Brian·2002·Journal of Neurochemistry

Abstract

Refsum's disease (hereditary motor sensory neuropathy type IV, heredopathia atactica polyneuritiformis) is an autosomal recessive disorder the clinical features of which include retinitis pigmentosa, blindness, anosmia, deafness, sensory neuropathy, ataxia and accumulation of phytanic acid in plasma‐ and lipid‐containing tissues. The transport and biochemical pathways of phytanic acid metabolism have recently been defined with the cloning of two key enzymes, phytanoyl‐CoA 2‐hydroxylase (PAHX) and 2‐hydroxyphytanoyl‐CoA lyase, together with the confirmation of their localization in peroxisomes. PAHX, an iron(II) and 2‐oxoglutarate‐dependent oxygenase is located on chromosome 10p13. Mutant forms of PAHX have been shown to be responsible for some, but not all, cases of Refsum's disease. Certain cases have been shown to be atypical mild variants of rhizomelic chondrodysplasia punctata type 1a. Other atypical cases with low‐plasma phytanic acid may be caused by α‐methylacyl‐CoA racemase deficiency. A sterol‐carrier protein‐2 (SCP‐2) knockout mouse model shares a similar clinical phenotype to Refsum's disease, but no mutations in SCP‐2 have been described to‐date in man. This review describes the clinical, biochemical and metabolic features of Refsum's disease and shows how the biochemistry of the α‐oxidation pathway may be linked to the regulation of metabolic pathways controlled by isoprenoid lipids, involving calcineurin or the peroxisomal proliferator activating α‐receptor.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.0022-3042.2002.00766.x

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 190

Metadata

Authors
Wierzbicki, A. S., Lloyd, M. D., Schofield, C. J., Feher, M. D., & Gibberd, F. B.
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
2002-03
Volume
80
Issue
5
Pages
727-735
ISSN
  • 0022-3042 (ISSN-L)
  • 1471-4159
OpenAlex
W2111315915
Cited by
190
References
4
FWCI
8.57
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Refsum's disease: a peroxisomal disorder affecting phytanic acid α‐oxidation. https://app.cochat.ai/papers/10.1046/j.0022-3042.2002.00766.x
The paper
Wierzbicki, A. S., Lloyd, M. D., Schofield, C. J., Feher, M. D., & Gibberd, F. B. (2002). Refsum's disease: a peroxisomal disorder affecting phytanic acid α‐oxidation. Journal of Neurochemistry. https://doi.org/10.1046/j.0022-3042.2002.00766.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.